Predict your next investment

Corporation
HEALTHCARE | Disease Diagnosis
orthoclinicaldiagnostics.com

See what CB Insights has to offer

Executives

16

Board of Directors

3

Ortho Clinical Diagnostics Board of Directors

3 Board of directors

Ortho Clinical Diagnostics has 3 board of directors, including David Perez.

Name

Firm

Work History

Other Seats

David Perez

Ortho Clinical Diagnostics

Martin Madaus

Martin brings more than 20 years of experience in the diagnostics and life science industries. He most recently served as President, Chairman and CEO of Millipore Corporation, recently acquired by Merck KGaA. Before joining Millipore, Dr. Madaus was President, CEO and head of North American Operations for Roche Diagnostics Corporation. Prior to this he served as Vice President of Business Development for Roche Molecular Diagnostics and General Manager of Boehringer Mannheim Canada. He also held a number of senior-level sales, marketing and product management positions with Boehringer Mannheim Corporation in both Germany and the US. Martin is a director of the Massachusetts High Technology Council and serves on the Life Sciences Collaborative Leadership Council of the Massachusetts Technology Collaborative. He holds a Doctor of Veterinary Medicine from the University of Munich, Germany and a Ph.D. in Veterinary Medicine from the Veterinary School of Hanover, Germany.

Ortho Clinical Diagnostics

Robert Schmidt

Robert R. Schmidt is a Principal on the U.S. Buyout team at The Carlyle Group, focused on private equity investments in the healthcare sector. He is based in New York. Since joining Carlyle in 2011, Mr. Schmidt has been involved in a number of the firm’s investments globally, including Beats Electronics, Grand Rounds Health, MedRisk, One Medical, Ortho Clinical Diagnostics and Sedgwick. He is currently a member of the Board of Directors of Grand Rounds Health, MedRisk, One Medical and Ortho Clinical Diagnostics. Prior to joining Carlyle, Mr. Schmidt worked at Welsh, Carson, Anderson & Stowe, a private equity firm focused on information business services and healthcare investments, and Merrill Lynch Global Private Equity, focused on buyouts in North America. Mr. Schmidt received his M.B.A. from Harvard Business School and a B.S. in economics from The Wharton School at the University of Pennsylvania.

Ortho Clinical Diagnostics

Name

David Perez

Martin Madaus

Robert Schmidt

Firm

Work History

Martin brings more than 20 years of experience in the diagnostics and life science industries. He most recently served as President, Chairman and CEO of Millipore Corporation, recently acquired by Merck KGaA. Before joining Millipore, Dr. Madaus was President, CEO and head of North American Operations for Roche Diagnostics Corporation. Prior to this he served as Vice President of Business Development for Roche Molecular Diagnostics and General Manager of Boehringer Mannheim Canada. He also held a number of senior-level sales, marketing and product management positions with Boehringer Mannheim Corporation in both Germany and the US. Martin is a director of the Massachusetts High Technology Council and serves on the Life Sciences Collaborative Leadership Council of the Massachusetts Technology Collaborative. He holds a Doctor of Veterinary Medicine from the University of Munich, Germany and a Ph.D. in Veterinary Medicine from the Veterinary School of Hanover, Germany.

Robert R. Schmidt is a Principal on the U.S. Buyout team at The Carlyle Group, focused on private equity investments in the healthcare sector. He is based in New York. Since joining Carlyle in 2011, Mr. Schmidt has been involved in a number of the firm’s investments globally, including Beats Electronics, Grand Rounds Health, MedRisk, One Medical, Ortho Clinical Diagnostics and Sedgwick. He is currently a member of the Board of Directors of Grand Rounds Health, MedRisk, One Medical and Ortho Clinical Diagnostics. Prior to joining Carlyle, Mr. Schmidt worked at Welsh, Carson, Anderson & Stowe, a private equity firm focused on information business services and healthcare investments, and Merrill Lynch Global Private Equity, focused on buyouts in North America. Mr. Schmidt received his M.B.A. from Harvard Business School and a B.S. in economics from The Wharton School at the University of Pennsylvania.

Other Seats

Ortho Clinical Diagnostics

Ortho Clinical Diagnostics

Ortho Clinical Diagnostics

Ortho Clinical Diagnostics Management Team

16 Team Members

Ortho Clinical Diagnostics has 16 executives. Ortho Clinical Diagnostics's current President, Senior Vice President is Heidi Frech Casaletto.

Name

Work History

Title

Status

Heidi Frech Casaletto

President, Senior Vice President

Current

Iris Lin

President

Current

Warren Stone

President

Current

Joe Busky CPA

Chief Financial Officer

Current

Thomas Schilbach

Chief Financial Officer

Current

Name

Heidi Frech Casaletto

Iris Lin

Warren Stone

Joe Busky CPA

Thomas Schilbach

Work History

Title

President, Senior Vice President

President

President

Chief Financial Officer

Chief Financial Officer

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.